Traditional and systems biology based drug discovery for the rare tumor syndrome neurofibromatosis type 2

Abstract excerpt

Neurofibromatosis 2 (NF2) is a rare tumor suppressor syndrome that manifests with multiple schwannomas and meningiomas. There are no effective drug therapies for these benign tumors and conventional therapies have limited efficacy. Various model systems have been created and several drug targets have been implicated in NF2-driven tumorigenesis based on known effects of the absence of merlin, the product of the...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Meningioma and schwannoma management
• Share to Neuroblastoma Research and Treatments
• Share to Neurofibromatosis and Schwannoma Cases